Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Hepatology

Diagnosis & Pitfalls: Understanding Your Test Results

At a Glance

Hepatitis Delta (HDV) diagnosis requires a three-step testing process that ends with an HDV RNA test to confirm active infection. Because HDV viral levels can naturally fluctuate and cause false negatives, doctors often recommend regular monitoring using the same laboratory for consistent results.

Navigating the world of lab tests for Hepatitis Delta (HDV) can be frustrating. Because HDV is a “defective” virus that relies on Hepatitis B, the testing process requires multiple steps, and the results can sometimes be inconsistent or confusing [1][2]. Understanding the “reflex” process and the pitfalls of current testing technology can help you advocate for the most accurate picture of your health.

The Reflex Testing Path: A Three-Step Journey

Most modern hospitals now use a reflex testing algorithm. This means the lab automatically performs the next necessary test as soon as a previous one comes back positive, saving you time and extra blood draws [3][4].

  1. HBsAg (Hepatitis B Surface Antigen): This is the first gate. Since HDV cannot exist without Hepatitis B, you are only screened for HDV if this test is positive [5].
  2. Anti-HDV (Total Antibodies): This test looks for the “memory” of the virus in your immune system [5]. A positive result means you have been exposed to HDV at some point, but it does not tell you if the virus is currently active [6].
  3. HDV RNA (Viral Load): This is the definitive test. It looks for the actual genetic material of the virus in your blood [5][7]. If this is positive, you have an active infection that requires medical management [6].

The Challenge of “Viral Blips” and Fluctuations

One of the most confusing aspects of HDV is that the viral load (HDV RNA) can fluctuate spontaneously [8]. You might have a high viral load one month and a much lower—or even undetectable—one the next, only for it to rise again later [9].

These “waves” or viral blips can lead to false negatives—a situation where a test says the virus isn’t there, even though it is still present in your liver [8][10]. Because of this, doctors often recommend longitudinal monitoring, which means testing your blood several times over many months to get a true “average” of your viral activity [8][9].

The Problem with Non-Standardized Tests

Unlike more common viruses like HIV or Hepatitis C, tests for HDV RNA are not always standardized across different laboratories [8].

  • Inter-laboratory Variability: If you send a blood sample to Lab A, they might use one method, while Lab B uses another. This can result in two different viral load numbers for the same patient [8][11].
  • Units of Measurement: Older tests might report results in “copies/mL,” while newer, standardized tests use “International Units” (IU/mL) based on World Health Organization standards [12][13]. It is very difficult to compare these two different units directly.

Checklist: What Should Be on Your Lab Report?

When you receive your lab results, look for these key details to ensure the test was comprehensive and useful for your doctor:

  • [ ] Test Name: Clearly labeled as “HDV RNA Quantitative” or “HDV PCR.”
  • [ ] Unit of Measurement: Ideally reported in IU/mL [12].
  • [ ] Limit of Detection (LoD): This is the lowest amount of virus the test can find. A “Not Detected” result is only as good as the LoD; if the LoD is high, the test might miss a low-level infection [14][8].
  • [ ] Quantification Limits (LOQ): The range in which the lab can accurately “count” the virus [15].
  • [ ] Genotype (Optional): While not always standard, knowing which of the 8 genotypes you have can sometimes help predict how your disease will progress [16][17].

If your result is “Not Detected,” ask your doctor if it might be a temporary fluctuation and when a follow-up test is scheduled to confirm that the virus is truly gone [8][10].

Common questions in this guide

What does a positive anti-HDV test mean?
A positive anti-HDV test means your immune system has antibodies against Hepatitis Delta, indicating you have been exposed to the virus. It does not confirm if you have an active infection, which requires an HDV RNA test to verify.
What is reflex testing for Hepatitis Delta?
Reflex testing is a multi-step process labs use to diagnose Hepatitis Delta efficiently from a single blood draw. If you test positive for Hepatitis B, the lab automatically checks for Hepatitis D antibodies, and if positive, runs an HDV RNA test.
Why might my HDV RNA test say 'Not Detected' if I still have the virus?
Hepatitis Delta viral loads can naturally fluctuate, causing temporary drops known as viral blips. If your blood is drawn during one of these blips, or if the lab's test limit of detection is too high, it can result in a false negative.
What specific details should I look for on my Hepatitis Delta lab report?
Your report should identify the test as HDV RNA Quantitative or PCR and report the results in International Units (IU/mL). You should also look for the Limit of Detection (LoD), which tells you the lowest amount of virus the test can accurately find.
Why do my HDV viral load numbers change when I use a different lab?
Hepatitis Delta testing is not yet fully standardized across all laboratories. Different labs may use different testing methods or units of measurement, which can result in different viral load numbers for the same blood sample.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does this lab use an assay calibrated to the WHO International Standard (IU/mL)?
  2. 2.What is the 'Limit of Detection' (LoD) for this specific test, and does it cover all HDV genotypes?
  3. 3.My results show a 'Not Detected' result today—could this be a 'viral blip' or fluctuation, and when should we re-test to be sure?
  4. 4.Since I tested positive for anti-HDV antibodies, is this reflex test for HDV RNA the final step in confirming an active infection?
  5. 5.How do these results compare to my previous Hepatitis B viral load? Are they being tested at the same time?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.

    Usai C, Gill US, Riddell AC, et al.

    Alimentary pharmacology & therapeutics 2022; (55(8)):978-993 doi:10.1111/apt.16807.

    PMID: 35292991
  2. 2

    Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.

    Wang W, Lempp FA, Schlund F, et al.

    Journal of hepatology 2021; (75(2)):311-323 doi:10.1016/j.jhep.2021.03.025.

    PMID: 33845061
  3. 3

    Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection.

    Cossiga V, Brusa S, Montalti R, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2024; (44(1)):148-154 doi:10.1111/liv.15746.

    PMID: 37789576
  4. 4

    The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies.

    Khattak A, Vongsavath T, Haque L, et al.

    Journal of clinical and experimental hepatology 2024; (14(5)):101395 doi:10.1016/j.jceh.2024.101395.

    PMID: 38617106
  5. 5

    Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' reply.

    Palom A, Riveiro-Barciela M, Buti M,

    Alimentary pharmacology & therapeutics 2020; (51(1)):174-175 doi:10.1111/apt.15558.

    PMID: 31850577
  6. 6

    Hepatitis D Viremia Among Injection Drug Users in San Francisco.

    Mahale P, Aka PV, Chen X, et al.

    The Journal of infectious diseases 2018; (217(12)):1902-1906 doi:10.1093/infdis/jiy157.

    PMID: 29800369
  7. 7

    Frequency of hepatitis D virus with different hepatitis B virus serological markers and coinfections in hospital patients from Argentina: synchronous testing of anti-HDV antibodies and HDV RNA.

    Giorgio M, Ramírez Ladino KA, López G, et al.

    European journal of gastroenterology & hepatology 2025; (37(1)):70-76 doi:10.1097/MEG.0000000000002857.

    PMID: 39373637
  8. 8

    One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease.

    Palom A, Sopena S, Riveiro-Barciela M, et al.

    Alimentary pharmacology & therapeutics 2021; (54(4)):462-469 doi:10.1111/apt.16485.

    PMID: 34181772
  9. 9

    HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy.

    Mangia A, Squillante MM, Fraticelli F, et al.

    Cells 2023; (12(10)) doi:10.3390/cells12101413.

    PMID: 37408247
  10. 10

    Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort.

    Nicolini LA, Menzaghi B, Ricci E, et al.

    Frontiers in medicine 2023; (10()):1086012 doi:10.3389/fmed.2023.1086012.

    PMID: 36778739
  11. 11

    Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study.

    Salpini R, Piermatteo L, Caviglia GP, et al.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2025; (180()):105850 doi:10.1016/j.jcv.2025.105850.

    PMID: 40784197
  12. 12

    Laboratory development of an RNA quantitative RT-PCR assay reporting in international units for hepatitis D virus.

    Osiowy C, Day J, Lee ER

    Frontiers in microbiology 2024; (15()):1472826 doi:10.3389/fmicb.2024.1472826.

    PMID: 39633803
  13. 13

    Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter study.

    Stelzl E, Berger A, Ciesek S, et al.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2025; (179()):105828 doi:10.1016/j.jcv.2025.105828.

    PMID: 40543190
  14. 14

    HDV RNA assays: Performance characteristics, clinical utility, and challenges.

    Wedemeyer H, Leus M, Battersby TR, et al.

    Hepatology (Baltimore, Md.) 2025; (81(2)):637-650 doi:10.1097/HEP.0000000000000584.

    PMID: 37640384
  15. 15

    Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

    Ghany MG, Buti M, Lampertico P, et al.

    Hepatology (Baltimore, Md.) 2023; (78(5)):1654-1673 doi:10.1097/HEP.0000000000000431.

    PMID: 37326326
  16. 16

    Epidemiology and phylogenetic analysis of hepatitis D virus infection in Australia.

    Jackson K, MacLachlan J, Cowie B, et al.

    Internal medicine journal 2018; (48(11)):1308-1317 doi:10.1111/imj.13967.

    PMID: 29761607
  17. 17

    Characterization of hepatitis delta virus strains spreading in Abuja, Nigeria.

    Ifeorah IM, Faleye TOC, Bakarey AS, et al.

    Journal of medical virology 2019; (91(9)):1688-1692 doi:10.1002/jmv.25503.

    PMID: 31081541

This page explains Hepatitis Delta lab testing terminology and processes for educational purposes. Always consult your hepatologist or healthcare provider to interpret your specific HDV RNA results.

Get notified when new evidence is published on Hepatitis delta.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.